Cargando…

Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis

Detalles Bibliográficos
Autores principales:	Liappas, Georgios, González-Mateo, Guadalupe, Aguirre, Anna Rita, Abensur, Hugo, Albar-Vizcaino, Patricia, Parra, Emilio González, Sandoval, Pilar, Ramírez, Laura García, del Peso, Gloria, Acedo, Juan Manuel, Bajo, María A., Selgas, Rafael, Sánchez Tomero, José A., López-Cabrera, Manuel, Aguilera, Abelardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410362/ https://www.ncbi.nlm.nih.gov/pubmed/28423612 http://dx.doi.org/10.18632/oncotarget.16782

Ejemplares similares

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT
por: González-Mateo, Guadalupe Tirma, et al.
Publicado: (2015)

Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis
por: Loureiro, Jesús, et al.
Publicado: (2013)

T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage
por: Liappas, Georgios, et al.
Publicado: (2015)

Corrigendum to “T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage”
por: Liappas, Georgios, et al.
Publicado: (2017)

Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?
por: Loureiro, Jesús, et al.
Publicado: (2013)

Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients
por: Ruiz-Carpio, Vicente, et al.
Publicado: (2017)

Functional Relevance of the Switch of VEGF Receptors/Co-Receptors during Peritoneal Dialysis-Induced Mesothelial to Mesenchymal Transition
por: Pérez-Lozano, María Luisa, et al.
Publicado: (2013)

Paricalcitol Reduces Peritoneal Fibrosis in Mice through the Activation of Regulatory T Cells and Reduction in IL-17 Production
por: González-Mateo, Guadalupe T., et al.
Publicado: (2014)

Actinomyces peritonitis: removal of the peritoneal catheter unnecessary for resolution
por: Díaz, R., et al.
Publicado: (2010)

Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition
por: Avila-Carrasco, Lorena, et al.
Publicado: (2019)

Abnormalities in Glucose Metabolism, Appetite-Related Peptide Release, and Pro-inflammatory Cytokines Play a Central Role in Appetite Disorders in Peritoneal Dialysis
por: Avila-Carrasco, Lorena, et al.
Publicado: (2019)

Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis
por: Ossorio, Marta, et al.
Publicado: (2017)

The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury
por: Nurlu Temel, Esra, et al.
Publicado: (2023)

Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid
por: Kopytina, Valeria, et al.
Publicado: (2022)

Increased miR-7641 Levels in Peritoneal Hyalinizing Vasculopathy in Long-Term Peritoneal Dialysis Patients
por: Díaz, Raquel, et al.
Publicado: (2020)

Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications
por: González, Elena, et al.
Publicado: (2016)

Protective measures against ultrafiltration failure in peritoneal dialysis patients
por: Aguirre, Anna Rita, et al.
Publicado: (2011)

Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis: In Vitro Downregulation by Vitamin D Receptor Agonists
por: Ossorio, Marta, et al.
Publicado: (2018)

TWEAK Promotes Peritoneal Inflammation
por: Sanz, Ana Belen, et al.
Publicado: (2014)

An Increase of Plasma Advanced Oxidation Protein Products Levels Is Associated with Cardiovascular Risk in Incident Peritoneal Dialysis Patients: A Pilot Study
por: Gonzalez, Elena, et al.
Publicado: (2015)

Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
por: Weiss, Robert
Publicado: (2006)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

A Novel Mouse Model of Peritoneal Dialysis: Combination of Uraemia and Long-Term Exposure to PD Fluid
por: Ferrantelli, E., et al.
Publicado: (2015)

Influence of dialysate temperature on creatinine peritoneal clearance in peritoneal dialysis patients: a randomized trial
por: Fontana, Francesco, et al.
Publicado: (2020)

Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis
por: Trionfetti, Flavia, et al.
Publicado: (2023)

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers
por: Schmidt, André C, et al.
Publicado: (2008)

Effect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension
por: Soanker, Radhika, et al.
Publicado: (2012)

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats
por: Nascimento, Mariana Moura, et al.
Publicado: (2022)

Nebivolol-induced gynecomastia
por: Köklü, Erkan, et al.
Publicado: (2015)

Kocuria salsicia peritonitis in a peritoneal dialysis patient
por: Fernández Girón, Fernando, et al.
Publicado: (2023)

Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling
por: Zhang, Zheng, et al.
Publicado: (2014)

Adrenergic Blockade by Nebivolol to Suppress Oral Squamous Cell Carcinoma Growth via Endoplasmic Reticulum Stress and Mitochondria Dysfunction
por: Chen, Qian, et al.
Publicado: (2021)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
por: Patel, Rachna S., et al.
Publicado: (2014)

Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
por: Terri, Michela, et al.
Publicado: (2021)

Evaluation of a system for sorbent‐assisted peritoneal dialysis in a uremic pig model
por: van Gelder, Maaike K., et al.
Publicado: (2020)

Alpha2B-Adrenergic Receptor Regulates Neutrophil Recruitment in MSU-Induced Peritoneal Inflammation
por: Duan, Lihua, et al.
Publicado: (2019)

α (1)-Adrenergic Receptor Blockade by Prazosin Synergistically Stabilizes Rat Peritoneal Mast Cells
por: Abe, Nozomu, et al.
Publicado: (2020)

(S,S,S,S)-Nebivolol hydrochloride hemihydrate
por: Rousselin, Yoann, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fpngirj0nag258liuc0389otls